KR20240108487A - 분변 중 엘라스테이스 1을 측정하는 방법 - Google Patents

분변 중 엘라스테이스 1을 측정하는 방법 Download PDF

Info

Publication number
KR20240108487A
KR20240108487A KR1020247020068A KR20247020068A KR20240108487A KR 20240108487 A KR20240108487 A KR 20240108487A KR 1020247020068 A KR1020247020068 A KR 1020247020068A KR 20247020068 A KR20247020068 A KR 20247020068A KR 20240108487 A KR20240108487 A KR 20240108487A
Authority
KR
South Korea
Prior art keywords
α1at
antitrypsin
reagent
complex
fecal sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247020068A
Other languages
English (en)
Korean (ko)
Inventor
아쓰시 사토
유타카 나가하마
Original Assignee
피에이치씨 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 피에이치씨 주식회사 filed Critical 피에이치씨 주식회사
Publication of KR20240108487A publication Critical patent/KR20240108487A/ko
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/966—Elastase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/067—Pancreatitis or colitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
KR1020247020068A 2021-11-30 2022-11-30 분변 중 엘라스테이스 1을 측정하는 방법 Pending KR20240108487A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021194361 2021-11-30
JPJP-P-2021-194361 2021-11-30
PCT/JP2022/044078 WO2023100910A1 (ja) 2021-11-30 2022-11-30 糞便中エラスターゼ１を測定する方法

Publications (1)

Publication Number Publication Date
KR20240108487A true KR20240108487A (ko) 2024-07-09

Family

ID=86612196

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247020068A Pending KR20240108487A (ko) 2021-11-30 2022-11-30 분변 중 엘라스테이스 1을 측정하는 방법

Country Status (6)

Country Link
US (1) US20250035630A1 (https=)
EP (1) EP4443160A4 (https=)
JP (1) JPWO2023100910A1 (https=)
KR (1) KR20240108487A (https=)
CN (1) CN118401838A (https=)
WO (1) WO2023100910A1 (https=)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6373152U (https=) 1986-10-31 1988-05-16
WO2002079782A1 (fr) 2001-03-30 2002-10-10 Mitsubishi Kagaku Iatron, Inc. Reactif et procede pour l'immunoanalyse de l'elastase 1, et procede de detection de pathologie pancreatique
JP2017516088A (ja) 2014-05-21 2017-06-15 ビュールマン ラボラトリーズ アクツィエンゲゼルシャフトＢｕｈｌｍａｎｎ Ｌａｂｏｒａｔｏｒｉｅｓ Ａｇ 蛋白の測定方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617299B2 (ja) * 1986-09-17 1997-06-04 ダイナボット 株式会社 エラスターゼ１の免疫学的測定方法
JPH03215747A (ja) * 1990-01-19 1991-09-20 Maruko Seiyaku Kk エラスターゼ１の酵素免疫学的測定方法および測定用試薬
DE4107765A1 (de) * 1990-07-28 1992-01-30 Schebo Tech Medizinisch Biolog Pankreas-elastase-1-spezifischer antikoerper, ein verfahren zu seiner gewinnung und ein testkit der solche antikoerper enthaelt
JP4530539B2 (ja) * 1998-09-08 2010-08-25 プリファテス インスティトゥット バイオサルフ ゲーエムベーハー 膵機能障害認識のための診断方法
DE10101792B4 (de) * 2001-01-17 2004-03-18 Vivotec Biomedical Technologies Gmbh Verfahren zum Nachweis von Pankreaskarzinom oder chronischer Pankreatitis und Verwendung von Antikörpern

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6373152U (https=) 1986-10-31 1988-05-16
WO2002079782A1 (fr) 2001-03-30 2002-10-10 Mitsubishi Kagaku Iatron, Inc. Reactif et procede pour l'immunoanalyse de l'elastase 1, et procede de detection de pathologie pancreatique
JP2017516088A (ja) 2014-05-21 2017-06-15 ビュールマン ラボラトリーズ アクツィエンゲゼルシャフトＢｕｈｌｍａｎｎ Ｌａｂｏｒａｔｏｒｉｅｓ Ａｇ 蛋白の測定方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Ann.Clin.Biochem 46;33-7,2009

Also Published As

Publication number Publication date
WO2023100910A1 (ja) 2023-06-08
EP4443160A4 (en) 2025-11-19
CN118401838A (zh) 2024-07-26
EP4443160A1 (en) 2024-10-09
US20250035630A1 (en) 2025-01-30
JPWO2023100910A1 (https=) 2023-06-08

Similar Documents

Publication Publication Date Title
CN105092855B (zh) 一种用于肝纤维化和肝硬化检测的试剂盒
JP2003524187A (ja) 体液、例えば尿におけるマーカーと血液凝固活性とを相互関連づけるための方法
JP4516124B2 (ja) 肝線維症の診断方法
US20070178442A1 (en) Method for diagnosing liver fibrosis
CN102656457A (zh) 用于诊断前列腺癌的试剂盒和方法
JP7483168B2 (ja) フェリチン測定試薬
US5552292A (en) Method of screening for colorectal cancer
EP1887358B1 (en) Method of immunologically analyzing plasmin degradation product of stabilized fibrin
US11320435B2 (en) Method of detecting proteins in human samples and uses of such methods
JP2010091308A (ja) レクチン吸収法による前立腺がんの診断方法及び判定キット
JP6578119B2 (ja) 前立腺特異抗原の測定方法及び測定キット
CN118638739B (zh) Gsdmd在胸痛相关疾病诊断及疗效评估上的用途
KR20240108487A (ko) 분변 중 엘라스테이스 1을 측정하는 방법
Huang et al. Development of a fluorescence immunochromatography method for quantitative measurement of matrix metalloproteinase-9
HK40109997A (en) Method for measuring elastase 1 in feces
EP4317991A1 (en) Highly sensitive immunoassay reagent and measurement method
CN109313193B (zh) 消化道癌的判定方法
Sun et al. Establishment of ABEI-based direct chemiluminescence immunoassays for PIC, TAT, tPAIC, and TM and their preliminary evaluation in thrombotic diseases
AU2017334408A1 (en) Point of care assays
JP3342819B2 (ja) 腎症の早期診断用キット
HK40106382A (en) Highly sensitive immunoassay reagent and measurement method
KR20240151234A (ko) 세린 프로테아제의 검출용 또는 측정용 시약
JPH0968524A (ja) 消化管疾患の検出方法
CN118759190A (zh) 用于测定tps的化学发光免疫测定clia试剂盒及测定tps的方法
CN121613114A (zh) 一种基于中性粒细胞迁移体及其标志物检测的弥散性血管内凝血早期诊断方法

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20240617

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application